Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:nickel group molecular entity
go back to main search page
Accession:CHEBI:33747 term browser browse the term
Synonyms:related_synonym: nickel group molecular entities



show annotations for term's descendants           Sort by:
 
cisplatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 multiple interactions EXP Cisplatin inhibits the reaction [ABCB1 protein results in increased susceptibility to NSC73306] CTD PMID:24800945 NCBI chr 9:93,049,955...93,146,469 JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 affects response to substance EXP AIFM1 protein affects the susceptibility to Cisplatin CTD PMID:15983031 NCBI chr  X:106,676,596...106,708,290
Ensembl chr  X:106,670,519...106,708,317
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions
affects localization
EXP Bezafibrate inhibits the reaction [Cisplatin affects the localization of BAX protein] CTD PMID:16316343 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,187,260...54,228,144
JBrowse link
G CASP2 caspase 2 increases expression EXP Cisplatin results in increased expression of CASP2 CTD PMID:12712633 NCBI chr18:6,946,432...6,966,088
Ensembl chr18:6,902,542...6,966,092
JBrowse link
G CASP3 caspase 3 increases expression
multiple interactions
increases activity
EXP Cisplatin results in increased expression of CASP3
[Cisplatin co-treated with EPO protein] results in increased cleavage of CASP3 protein; Bezafibrate inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]; Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein
CTD PMID:12712633 PMID:16316343 PMID:20435919 PMID:21497595 NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,749...45,763,773
JBrowse link
G CASP8 caspase 8 increases activity
increases expression
multiple interactions
EXP Cisplatin results in increased activity of CASP8 protein
Cisplatin results in increased expression of CASP8
Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP8 protein]
CTD PMID:12712633 PMID:20435919 NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,470
JBrowse link
G CASP9 caspase 9 increases expression
increases activity
EXP Cisplatin results in increased expression of CASP9
Cisplatin results in increased activity of CASP9 protein
CTD PMID:12712633 PMID:20435919 NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,515...74,730,092
JBrowse link
G CYCS cytochrome c, somatic affects localization
multiple interactions
EXP Cisplatin affects the localization of CYCS protein
Bezafibrate inhibits the reaction [Cisplatin affects the localization of CYCS protein]
CTD PMID:16316343 NCBI chr18:47,169,921...47,172,212
Ensembl chr18:47,169,866...47,173,866
JBrowse link
G EPO erythropoietin multiple interactions EXP [Cisplatin co-treated with EPO protein] results in increased cleavage of CASP3 protein CTD PMID:21497595 NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
JBrowse link
G FAS Fas cell surface death receptor increases expression EXP Cisplatin results in increased expression of FAS mRNA CTD PMID:20435919 NCBI chr14:100,927,305...100,954,781 JBrowse link
G FASLG Fas ligand multiple interactions
affects localization
EXP Cilastatin inhibits the reaction [Cisplatin affects the localization of FASLG protein] CTD PMID:20435919 NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,475
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit multiple interactions EXP Buthionine Sulfoximine inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein]]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of GCLC protein] CTD PMID:20732396 NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,564...27,253,535
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
EXP Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of MYC] CTD PMID:12712633 NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,119...12,461,078
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions EXP Dicumarol inhibits the reaction [sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein]]; sulforaphane inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein] CTD PMID:20732396 NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,769...17,302,590
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases activity
multiple interactions
EXP Cisplatin results in increased activity of PARP1 protein
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Cisplatin results in increased activity of PARP1 protein]
CTD PMID:25806124 NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,159...14,241,197
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha decreases activity
multiple interactions
EXP Cisplatin results in decreased activity of PPARA protein
[Cisplatin results in decreased activity of PPARA protein] which results in increased abundance of Fatty Acids, Nonesterified; Bezafibrate inhibits the reaction [[Cisplatin results in decreased activity of PPARA protein] which results in increased abundance of Fatty Acids, Nonesterified]; Bezafibrate inhibits the reaction [Cisplatin results in decreased activity of PPARA protein]
CTD PMID:16316343 NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,708...3,366,361
JBrowse link
G TNF tumor necrosis factor increases expression EXP Cisplatin results in increased expression of TNF mRNA CTD PMID:20435919 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
JBrowse link
G TP53 tumor protein p53 increases expression
multiple interactions
EXP Cisplatin results in increased expression of TP53
mangostin inhibits the reaction [Cisplatin results in increased expression of TP53]
CTD PMID:12712633 PMID:20603111 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,643...52,953,819
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 1029
    chemical entity 1029
      molecular entity 1016
        transition element molecular entity 196
          nickel group molecular entity 18
            darmstadtium molecular entity 0
            nickel molecular entity + 0
            palladium molecular entity + 0
            platinum molecular entity + 18
Path 2
Term Annotations click to browse term
  CHEBI ontology 1029
    subatomic particle 1003
      composite particle 1014
        hadron 1014
          baryon 1014
            nucleon 1014
              atomic nucleus 1014
                atom 1014
                  metal atom 235
                    transition element atom 198
                      d-block element atom 196
                        nickel group element atom 20
                          nickel group molecular entity 18
                            darmstadtium molecular entity 0
                            nickel molecular entity + 0
                            palladium molecular entity + 0
                            platinum molecular entity + 18
paths to the root